These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18787407)

  • 1. Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma.
    Mantoni TS; Schendel RR; Rödel F; Niedobitek G; Al-Assar O; Masamune A; Brunner TB
    Cancer Biol Ther; 2008 Nov; 7(11):1806-15. PubMed ID: 18787407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
    Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
    Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of SPARC expression in pancreatic cancer progression and patient survival.
    Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
    Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
    Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma.
    Khetan K; Baloda V; Sahoo RK; Vishnubhathla S; Yadav R; Saraya A; Sharma A; Gupta SD; Das P
    Pathol Res Pract; 2019 Dec; 215(12):152685. PubMed ID: 31727501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
    Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
    Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between SPARC, TGFβ1, Endoglin and angiogenesis mechanism in lung cancer.
    Wang B; Zhang Z; Tang J; Tao H; Zhang Z
    J Biol Regul Homeost Agents; 2018; 32(6):1525-1531. PubMed ID: 30574760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
    Arnold SA; Rivera LB; Carbon JG; Toombs JE; Chang CL; Bradshaw AD; Brekken RA
    PLoS One; 2012; 7(2):e31384. PubMed ID: 22348081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated stromal fibroblasts promote pancreatic tumor progression.
    Hwang RF; Moore T; Arumugam T; Ramachandran V; Amos KD; Rivera A; Ji B; Evans DB; Logsdon CD
    Cancer Res; 2008 Feb; 68(3):918-26. PubMed ID: 18245495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.
    Al-Assar O; Bittner MI; Lunardi S; Stratford MR; McKenna WG; Brunner TB
    Radiother Oncol; 2016 May; 119(2):300-5. PubMed ID: 27247056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
    Takayama H; Kobayashi S; Gotoh K; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Asaoka T; Noda T; Wada H; Takahashi H; Tanemura M; Doki Y; Eguchi H
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10935-10950. PubMed ID: 37330435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal expression of SPARC in pancreatic adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Cros J; Faivre S; Hammel P; Raymond E
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):585-602. PubMed ID: 23690170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer.
    Hasselluhn MC; Klein L; Patzak MS; Buchholz SM; Ströbel P; Ellenrieder V; Maisonneuve P; Neesse A
    Cells; 2019 Dec; 9(1):. PubMed ID: 31878349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.
    Byrling J; Sasor A; Nilsson J; Said Hilmersson K; Andersson R; Andersson B
    Scand J Gastroenterol; 2020 Jun; 55(6):725-731. PubMed ID: 32543919
    [No Abstract]   [Full Text] [Related]  

  • 17. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
    Xiao Y; Zhang H; Ma Q; Huang R; Lu J; Liang X; Liu X; Zhang Z; Yu L; Pang J; Zhou L; Liu T; Wu H; Liang Z
    Cancer Lett; 2019 Oct; 462():51-60. PubMed ID: 31352078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal heterogeneity in pancreatic cancer and chronic pancreatitis.
    Haeberle L; Steiger K; Schlitter AM; Safi SA; Knoefel WT; Erkan M; Esposito I
    Pancreatology; 2018 Jul; 18(5):536-549. PubMed ID: 29778400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8.
    Wang HC; Lin YL; Hsu CC; Chao YJ; Hou YC; Chiu TJ; Huang PH; Tang MJ; Chen LT; Shan YS
    Theranostics; 2019; 9(24):7168-7183. PubMed ID: 31695760
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma.
    Pomianowska E; Sandnes D; Grzyb K; Schjølberg AR; Aasrum M; Tveteraas IH; Tjomsland V; Christoffersen T; Gladhaug IP
    BMC Cancer; 2014 Jun; 14():413. PubMed ID: 24912820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.